REGENERIS MEDICAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease
Phase 1
Not yet recruiting
- Conditions
- Cyotokine StormCovid-19 Pneumonia
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 20
- Registration Number
- NCT04352803
Autologous Stem/Stromal Cells in Neurological Disorders and Disease
Not Applicable
- Conditions
- DementiaAltered Behavior in Alzheimer DiseaseCorticobasal DegenerationParkinsonDemyelinating Autoimmune Diseases, CNSDemyelinating Sensorimotor Neuropathy
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 300
- Registration Number
- NCT03297177
- Locations
- 🇺🇸
Regeneris Medical Inc, North Attleboro, Massachusetts, United States
🇺🇸Regeneris Medical, North Attleboro, Massachusetts, United States
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
Not Applicable
Recruiting
- Conditions
- Alopecia AreataScarring Alopecia
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Regeneris Medical
- Target Recruit Count
- 60
- Registration Number
- NCT03078686
- Locations
- 🇺🇸
Kenneth Williams, DO, Irvine, California, United States
🇺🇸Regeneris Medical, North Attleboro, Massachusetts, United States
🇺🇸Regenevita LLC, Stevensville, Montana, United States
News
No news found